VRNA logo

Verona Pharma plc (VRNA)

Profile

Full Name

Verona Pharma plc

Ticker

NASDAQ: VRNA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United Kingdom

IPO

April 28, 2017

Indexes

Not included

Website

http://www.veronapharma.com

Employees

209

Key Details

Price

$104.90(+0.11%)

Market cap

$8.93B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$42.28M

Annual EPS

-$2.16(-200.00% YoY)

PE ratio

-

Next earnings date

Aug 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $104.90
    VRNA price is $104.90

    30-Day Relative Volume

    0.56
    VRNA 30-day relative volume is 0.56

    Price Performance

    Price Most recent change

    +0.11%
    VRNA price was up +0.11% on Jul 18, 2025

    Price YTD change

    +125.88%
    VRNA price is up +125.88% since January 1st

    Price 1-year change

    +364.57%
    VRNA price is up +364.57% year-on-year

    Price 3-year change

    +1696.23%
    VRNA price is up +1696.23% over the past 3 years

    Price Range

    Price All-time high

    $105.30
    VRNA price is currently -0.38% below its historical high of $105.30

    Price 3-year low

    $5.19
    VRNA price is currently +1921.19% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $8.93B
    VRNA market capitalization is $8.93 billion

    Market cap 3-year change

    +2420.79%
    VRNA market capitalization is up +2420.79% over the past 3 years

    Market cap All-time high

    $8.93B
    VRNA market capitalization is currently at an all-time high

    Market cap sector rank

    91.97%
    VRNA market capitalization is higher than 91.97% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +5%
    VRNA shares outstanding is up +5% year-on-year

    Shares Outstanding 3-Year Change

    +40.34%
    VRNA shares outstanding is up +40.34% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.98
    VRNA beta is 0.98

    200-day SMA

    $59.50
    VRNA price is currently +76.31% above its 200-day simple moving average

    50-day SMA

    $86.39
    VRNA price is currently +21.42% above its 50-day simple moving average

    RSI

    70.68
    VRNA 14-day relative strength index is 70.68

    Volume

    0.56
    VRNA 30-day relative volume is 0.56

    ATR

    $2.18
    VRNA average true range is $2.18

    10-day Historical Volatility

    108.91%
    VRNA 10-day historical volatility is 108.91%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $42.28M
    VRNA annual revenue is $42.28 million

    Revenue Analysts estimate

    $312.70M
    VRNA annual revenue is currently -86.48% lower than the consensus analysts' forecast

    Revenue 1-year change

    -
    VRNA annual revenue 1-year change is unknown

    Revenue Sector rank

    44.43%
    VRNA annual revenue is higher than 44.43% of companies in Healthcare sector

    EPS

    EPS

    -$2.16
    VRNA annual earnings per share is -$2.16

    EPS Analysts estimate

    $1.18
    VRNA annual earnings per share is currently -283.05% lower than the consensus analysts' forecast

    EPS 1-year change

    -200%
    VRNA annual earnings per share is down -200% year-on-year

    EPS Sector rank

    37.75%
    VRNA annual earnings per share is higher than 37.75% of companies in Healthcare sector

    Profit

    Gross profit

    $39.70M
    VRNA annual gross profit is $39.70 million

    Gross margin

    93.89%
    VRNA annual gross profit margin is 93.89%

    Operating profit

    -$151.03M
    VRNA annual operating income is -$151.03 million

    Operating margin

    -357.22%
    VRNA annual operating profit margin is -357.22%

    Net income

    -$173.42M
    VRNA annual net profit is -$173.42 million

    Net margin

    -410.18%
    VRNA annual net profit margin is -410.18%

    Expenses

    Total expenses

    $193.31M
    VRNA annual total expenses is $193.31 million

    Operating expenses

    $190.72M
    VRNA annual total operating expenses is $190.72 million

    Cost of goods sold

    $2.58M
    VRNA annual cost of goods sold is $2.58 million

    Selling, general & administrative expenses

    $149.75M
    VRNA annual SGA is $149.75 million

    Depreciation and amortization

    $1.06M
    VRNA annual depreciation & amortization is $1.06 million

    Interest expense

    $23.54M
    VRNA annual interest expense is $23.54 million

    Income tax

    $10.29M
    VRNA annual income tax is $10.29 million

    EBIT & EBITDA

    EBIT

    -$139.59M
    VRNA annual earnings before interest & taxes is -$139.59 million

    EBITDA

    -$138.53M
    VRNA annual EBITDA is -$138.53 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $474.24M
    VRNA annual total assets is $474.24 million

    Non current assets

    $20.67M
    VRNA annual long term assets is $20.67 million

    Current assets

    $453.57M
    VRNA annual total current assets is $453.57 million

    Cash and cash equivalents

    $399.76M
    VRNA annual cash & cash equivalents is $399.76 million

    Accounts receivable

    $31.50M
    VRNA annual accounts receivable is $31.50 million

    Inventory

    $6.25M
    VRNA annual inventory is $6.25 million

    Liabilities

    Total liabilities

    $269.68M
    VRNA annual total liabilities is $269.68 million

    Long term liabilities

    $227.00M
    VRNA annual total long term liabilities is $227.00 million

    Current liabilities

    $42.68M
    VRNA annual total current liabilities is $42.68 million

    Accounts payable

    $11.27M
    VRNA annual accounts payable is $11.27 million

    Debt

    Total debt

    $122.70M
    VRNA annual total debt is $122.70 million

    Total debt 1-year change

    +139.05%
    VRNA annual total debt is up +139.05% year-on-year

    Long term debt

    $121.58M
    VRNA annual long term debt is $121.58 million

    Short term debt

    $1.12M
    VRNA annual short term debt is $1.12 million

    Equity & Capital

    Shareholders equity

    $204.56M
    VRNA annual stockholders equity is $204.56 million

    Book value

    $204.56M
    VRNA annual book value is $204.56 million

    Retained earnings

    -$562.40M
    VRNA annual retained earnings is -$562.40 million

    Working capital

    $410.89M
    VRNA annual working capital is $410.89 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$122.20M
    VRNA annual cash flow from operations is -$122.20 million

    Cash from operations 1-year change

    -143.33%
    VRNA annual cash flow from operations is down -143.33% year-on-year

    Cash from investing

    -$580.00K
    VRNA annual cash flow from investing activities is -$580.00 thousand

    Cash from investing 1-year change

    -100%
    VRNA annual cash flow from investing activities is down -100% year-on-year

    Cash from financing

    $250.78M
    VRNA annual cash flow from financing activities is $250.78 million

    Cash from financing 1-year change

    +170.04%
    VRNA annual cash flow from financing activities is up +170.04% year-on-year

    CAPEX

    CAPEX

    $580.00K
    VRNA annual capital expenditures is $580.00 thousand

    CAPEX 1-year change

    -
    VRNA annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$122.78M
    VRNA annual free cash flow is -$122.78 million

    Free cash flow 1-year change

    -144.48%
    VRNA annual free cash flow is down -144.48% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    93.89%
    VRNA annual gross profit margin is 93.89%

    Operating margin

    -357.22%
    VRNA annual operating profit margin is -357.22%

    Net margin

    -410.18%
    VRNA annual net profit margin is -410.18%

    ROA & ROE

    ROA

    -44.33%
    VRNA annual return on assets is -44.33%

    ROE

    -76.42%
    VRNA annual return on equity is -76.42%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    VRNA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    VRNA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    39.41
    VRNA price to book ratio is 39.41

    PB ratio Sector rank

    97.59%
    VRNA price to book ratio is higher than 97.59% of companies in Healthcare sector

    PS Ratio

    PS ratio

    75.34
    VRNA price to sales ratio is 75.34

    PS ratio Sector rank

    93.16%
    VRNA price to sales ratio is higher than 93.16% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $8.77B
    VRNA enterprise value is $8.77 billion

    Enterprise value Sector rank

    91.14%
    VRNA enterprise value is higher than 91.14% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -72.26
    VRNA EV/EBITDA is -72.26

    EV/EBITDA Sector rank

    2.73%
    VRNA EV/EBITDA is higher than 2.73% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    10.63
    VRNA annual current ratio is 10.63

    Quick ratio

    10.48
    VRNA annual quick ratio is 10.48

    Leverage

    Debt to equity

    0.59
    VRNA annual debt to equity ratio is 0.59

    Interest coverage ratio

    -5.93
    VRNA annual interest coverage ratio is -5.93

    Risk & Stability

    Piotroski F-Score

    -
    VRNA piotroski f-score value is unknown

    Altman Z-Score

    18.37
    VRNA altman z-score is 18.37

    Analyst ratings

    Recent major analysts updates

    Jul 14, 25 HC Wainwright & Co.
    Neutral
    Jul 10, 25 Wells Fargo
    Equal-Weight
    Jul 10, 25 BTIG
    Neutral
    Jul 9, 25 Jefferies
    Hold
    Jul 9, 25 Canaccord Genuity
    Hold
    Jul 1, 25 Wolfe Research
    Outperform
    Jun 23, 25 Piper Sandler
    Overweight
    Jun 20, 25 Wells Fargo
    Overweight
    Jun 18, 25 Roth Capital
    Buy
    Jun 11, 25 Jefferies
    Buy

    Institutional Ownership

    Screeners with VRNA included

    Growing Shares Outstanding
    Mid cap stocks
    UK stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    • What is the ticker symbol for Verona Pharma plc?
    • Does Verona Pharma plc pay dividends?
    • What sector is Verona Pharma plc in?
    • What industry is Verona Pharma plc in?
    • What country is Verona Pharma plc based in?
    • When did Verona Pharma plc go public?
    • Is Verona Pharma plc in the S&P 500?
    • Is Verona Pharma plc in the NASDAQ 100?
    • Is Verona Pharma plc in the Dow Jones?
    • When was Verona Pharma plc's last earnings report?
    • When does Verona Pharma plc report earnings?

    What is the ticker symbol for Verona Pharma plc?

    The ticker symbol for Verona Pharma plc is NASDAQ:VRNA

    Does Verona Pharma plc pay dividends?

    No, Verona Pharma plc does not pay dividends

    What sector is Verona Pharma plc in?

    Verona Pharma plc is in the Healthcare sector

    What industry is Verona Pharma plc in?

    Verona Pharma plc is in the Biotechnology industry

    What country is Verona Pharma plc based in?

    Verona Pharma plc is headquartered in United Kingdom

    When did Verona Pharma plc go public?

    Verona Pharma plc's initial public offering (IPO) was on April 28, 2017

    Is Verona Pharma plc in the S&P 500?

    No, Verona Pharma plc is not included in the S&P 500 index

    Is Verona Pharma plc in the NASDAQ 100?

    No, Verona Pharma plc is not included in the NASDAQ 100 index

    Is Verona Pharma plc in the Dow Jones?

    No, Verona Pharma plc is not included in the Dow Jones index

    When was Verona Pharma plc's last earnings report?

    Verona Pharma plc's most recent earnings report was on April 29, 2025

    When does Verona Pharma plc report earnings?

    The next expected earnings date for Verona Pharma plc is August 8, 2025
    On this page